The e-commerce platform beats quarterly estimates for revenue and gross merchandise volume.

Salesforce is expected to roll-out full version of its largely anticipated Agentforce 2.0 offering, which is extremely likely to be a game-changer in terms of the share price. Apart from the expected Agentforce 2.0 full release, there are several other developments emphasizing the management's strong focus on AI. My valuation analysis suggests that the stock is significantly undervalued.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128743&wire=1 or contact Joseph E. Levi, Esq.

Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital Market Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital Market

BEIJING, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced a major upgrade to its CHEERS video platform (“CHEERS”). As consumer demand for personalization in the home goods market continues to rise, coupled with a younger and more personalized user base, the need for diverse and refined functional home solutions is increasing. as a premier lifestyle content aggregation platform, CHEERS is keenly attuned to market changes and has undergone a critical upgrade and optimization since its launch.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128741&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128742&wire=1 or contact Joseph E.

MIAMI, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq / TSXV: DGHI), is proud to announce the formation of US Data Centers, Inc. (“US Data Centers”), a wholly-owned subsidiary of the Company which will be dedicated to the development of high-performance computing (“HPC”) and artificial intelligence (“AI”)-focused data centers. The new US Data Centers website can be found at www.usdatacenters.ai.

Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128740&wire=1 or contact Joseph E. Levi, Esq.

DuPont cited continued recovery in semiconductor demand, driven primarily by AI-technology applications and stronger demand in China, for its results.

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated for FSGS, a rare kidney disorder and leading cause of kidney failure sNDA submission to be based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS Company to host conference call and webcast today at 8:30 a.m. ET SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the Company has completed its Type C meeting …

Monday.com NASDAQ: MNDY can hit new all-time highs this year because it capitalizes on AI and business automation like every other technology company would be happy to accomplish. It is growing its user base, deepening penetration of services, and doing so among the world's largest businesses.

NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ: NXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Nextracker securities between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period").

Fourth quarter 2024 RevPAR 1 increased 5.0 percent worldwide, with 4.1 percent growth in the U.S. & Canada and 7.2 percent growth in international markets Fourth quarter reported diluted EPS totaled $1.63 and adjusted diluted EPS totaled $2.45 Fourth quarter reported net income totaled $455 million and adjusted net income totaled $686 million Fourth quarter adjusted EBITDA totaled $1,286 million With record gross room additions of over 123,000 in 2024, net rooms grew 6.8 percent from year-end 2023 At the end of the year, Marriott's worldwide development pipeline totaled nearly 3,800 properties and over 577,000 rooms The company returned over …

ROCKVILLE, Md. , Feb. 11, 2025 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, today announced that ListenAI Technology (ListenAI), a pioneering leader in intelligent terminal system-on-chip (SoC) solutions, has licensed the Ceva-Waves Wi-Fi 6 IP to enhance its portfolio of Edge AI processors.

2,100 Homes Expected to be Powered by these Community Solar Projects TORONTO , Feb. 11, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company") is pleased to announce an update on the development of two projects located on industrial brownfield sites located in Skaneateles, New York which is in the Finger Lakes Retion of New York, in Onnodaga County. The Company intends to develop two ground-mount community solar projects across the this site with a capacity of 14.4 MW DC (the "Projects").

Fountain Valley, California--(Newsfile Corp. - February 11, 2025) - Moving iMage Technologies (NYSE American: MITQ) will host a conference call discussing financial and operational results for its second quarter of 2025 ended December 31, 2024, on Thursday, February 13, 2025 at 11:00 a.m. Eastern Time.

NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired MGP Ingredients securities between May 3, 2023 and October 30, 2024, both dates inclusive (the "Class Period").

Company continues to explore and review strategic options focused on maximizing shareholder value SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Feb. 11, 2025 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and development programs, has been focused on developing novel therapies for the treatment of prostate cancer, today reported financial results for the fiscal first quarter ended December 31, 2024. "Following our decision to terminate the clinical development of masofaniten, we have been evaluating and reviewing strategic options with a focus on maximizing shareholder …